Uterine diseases
Conditions
Interventions
A: Bupivacaine liposome group :For patients undergoing laparoscopic transabdominal total hysterectomy, after general anesthesia with endotracheal intubation, Group A: 20ml (266mg) of bupivacaine li
B: levobupivacaine hydrochloride group:For patients undergoing laparoscopic transabdominal total hysterectomy, after general anesthesia with endotracheal intubation, Group B received bilateral lumbar
Sponsors
The Second Affiliated Hospital of Hainan Medical College
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Age: 18-70 years old, Body Mass Index (BMI): 18-30kg/m2; (2) American Society of Anesthesiologists (ASA) classification: I-III; (3) No concurrent heart, liver, or kidney diseases; (4) The patient plans to undergo laparoscopic transabdominal total hysterectomy; (5) Normal coagulation function and platelet function; (6) <3 hours during surgery; (7) The patient or family agrees and signs an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Individuals allergic to bupivacaine; (2) Infection at the puncture site is not suitable for nerve block operators; (3) Opioid addicts; (4) Patients with severe consciousness disorders or those with mental and cognitive impairments. (5) Patients with combined heart, liver, kidney diseases, and coagulation dysfunction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS pain score;First analgesia pump compression time;Number of compressions of analgesic pump;The usage of opioid drugs;Duration of continuous analgesia; | — |
Secondary
| Measure | Time frame |
|---|---|
| Nauseated;Vomiting;Dizzy;Headache;Hypersomnia;Hypotension;Hypertension;Lower limb muscle strength; | — |
Countries
China
Contacts
Public ContactWei Xuemei
The Second Affiliated Hospital of Hainan Medical College
Outcome results
None listed